New Results
Mendelian randomization does not support serum calcium in prostate cancer risk
James Yarmolinsky, Katie Berryman, Ryan Langdon, Carolina Bonilla, the PRACTICAL consortium, George Davey Smith, Richard M Martin, Sarah J Lewis
doi: https://doi.org/10.1101/297721
James Yarmolinsky
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Katie Berryman
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Ryan Langdon
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Carolina Bonilla
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
3Department of Preventive Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil
George Davey Smith
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
4National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol
Richard M Martin
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
4National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol
Sarah J Lewis
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Article usage
Posted April 09, 2018.
Mendelian randomization does not support serum calcium in prostate cancer risk
James Yarmolinsky, Katie Berryman, Ryan Langdon, Carolina Bonilla, the PRACTICAL consortium, George Davey Smith, Richard M Martin, Sarah J Lewis
bioRxiv 297721; doi: https://doi.org/10.1101/297721
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8749)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12086)
- Cell Biology (17403)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16795)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11582)
- Neuroscience (60936)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10423)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)